Interim report January-September 2005

• Turnover increased to SEK 90.0 (79.3) million, an increase of 14 percent. During the third quarter sales increased by 21 percent to SEK 29.2 (24.1) million. • Gross income increased by 9 percent to SEK 62.0 (56.9) million and the gross margin amounted to 69 (72) percent. Gross income for the third quarter increased by 14 percent to SEK 20.2 (17.6) million and the gross margin was 69 (73) percent. • Operating income amounted to SEK 9.7 (12.0) million for the first nine months of 2005 and to SEK 3.2 (3.4) million for the third quarter. • Income after financial items was SEK 12.3 (12.2) million, of which SEK 3.0 (3.2) million was for the third quarter. • Net income for the Group was SEK 12.0 (12.4) million, of which SEK 2.9 million (3.3) was for the third quarter. • Earnings per share amounted to SEK 0.65 (0.68). • The equity/assets ratio increased to 83 percent (81). • Cash flow during the third quarter amounted to SEK 6.2 (-4.5) million, which means that the cash flow for the whole period was also positive, SEK 0.5 (-6.5) million. • The growth in sales of fertility products in Europe during the third quarter was 21 percent. • The warrants program directed at the personnel was over-subscribed by 30 percent. • New sales director for Europe/Asia has been recruited. October 27, 2005 Kungsbacka, Sweden Magnus Nilsson CEO Questions should be addressed to: Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61. Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.

---